Court: Humira Programs Did Not Violate Anti-Kickback Statute

Oops! Subscribers must be logged in to access this content.

Not A Thompson FDA Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the FDA Compliance Expert Suite.

Subscription Benefits

Start Your Free Trial

By signing up for a tour of the Thompson FDA Compliance Expert Suite, you are also registering to receive email offers and product updates from us. Simply click unsubscribe at the bottom of any email if you would like to discontinue delivery.

Court: Patient- and Provider-Support Programs for Humira Did Not Violate Anti-Kickback Statute

Dennis Tosh

July 16, 2025 at 04:21 PM EST

A federal district court in Illinois has granted summary judgment in favor of AbbVie Inc. and two corporate officials in a suit in which shareholders alleged that two company programs linked to the company’s rheumatoid arthritis medication Humira that purportedly violated the Anti-Kickback Statute had been fraudulently concealed from the investors (Holwill v. AbbVie Inc., No. ... Read More

My Research Folders

You are not Logged in yet, Please login to see Your research folders.

Oops! Subscribers must be logged in to access this content.

Not A Thompson FDA Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the FDA Compliance Expert Suite.

Subscription Benefits

Start Your Free Trial

Court: Patient- and Provider-Support Programs for Humira Did Not Violate Anti-Kickback Statute

My Research Folders

THOMPSON FDA

COMPLIANCE EXPERT

RESOURCES

HELP

CONTACT